These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19559336)

  • 1. Overcoming challenges to influenza vaccination in patients with CKD.
    Kallen AJ; Fiore AE
    Am J Kidney Dis; 2009 Jul; 54(1):6-9. PubMed ID: 19559336
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J; Peetermans WE; Vanwalleghem J; Maes B; Bammens B; Claes K; Osterhaus AD; Vanrenterghem Y; Evenepoel P
    Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flu vaccination rates: how can you do better?
    Campos-Outcalt D
    J Fam Pract; 2007 Oct; 56(10):825-6, 828. PubMed ID: 17908513
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination of a group of young people with influenza virus A/New Jersey/ 1976 (Hsw 1 N 1)].
    Masurel N; de Jong P; Verhoeff WF
    Ned Tijdschr Geneeskd; 1977 Nov; 121(45):1794-800. PubMed ID: 927558
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses.
    Aymard M; Bentejac MC; Larbaigt G; Michaut D; Triau R
    Dev Biol Stand; 1979; 43():231-9. PubMed ID: 520670
    [No Abstract]   [Full Text] [Related]  

  • 7. Best practice from a health plan standpoint: the 'who, how, and when' of influenza immunization.
    Tzeel A
    Manag Care; 2007 Aug; 16(8 Suppl 8):10-2; discussion 17-9. PubMed ID: 17927018
    [No Abstract]   [Full Text] [Related]  

  • 8. Attitudes of Wisconsin pediatricians toward influenza immunization.
    Edwards NM; Baumann-Blackmore NL; Saari TN
    WMJ; 2011 Apr; 110(2):63-7. PubMed ID: 21560559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of immunogenicity and safety of domestic influenza vaccines].
    Yao J; Li Q; Xu Q; Feng CF; Lu YM; Xu BQ; Lu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):735. PubMed ID: 15555412
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of influenza vaccination].
    Hannoun C
    Rev Med Suisse Romande; 1974 Apr; 94(4):319-23. PubMed ID: 4826392
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preventive influenza vaccination--possibilities and limits in the prevention of influenza-virus infections].
    Wesselius-de Casparis A
    Med Monatsschr; 1973 Oct; 27(10):447-9. PubMed ID: 4777787
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake of influenza immunisation among GPs in the Cork area.
    Connolly B; Connolly M; Rochford S
    Ir Med J; 2009 Jun; 102(6):193-4. PubMed ID: 19725174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies in influenza vaccines].
    Kunz C; Wiedermann G; Dostal V
    Wien Med Wochenschr; 1975 Oct; 125(40):581-2. PubMed ID: 1226778
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza 1980-1.
    Br Med J; 1980 Aug; 281(6239):527-8. PubMed ID: 7427354
    [No Abstract]   [Full Text] [Related]  

  • 15. [Summary of the practice guideline 'Influenza and influenza vaccination' (first revision) from the Dutch College of General Practitioners].
    Opstelten W; van Essen GA; van der Laan JR; Geijer RM; Goudswaard AN
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2116-9. PubMed ID: 18856027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The practice guideline 'Influenza and influenza vaccination' (first revision) from the Dutch College of General Practitioners; a response from the perspective of general practice].
    Hopstaken RM; Cals JW
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2108-10. PubMed ID: 18856024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
    Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
    Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac rehabilitation as a site for influenza vaccination?
    Davis MM
    J Cardiopulm Rehabil Prev; 2007; 27(4):210-1. PubMed ID: 17667015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influenza vaccination. Measurement of antibodies in blood samples before and after vaccination].
    Kolstø AB; Birkeland Flugsrud L; Halvorsrud J
    Tidsskr Nor Laegeforen; 1985 Jun; 105(19-21):1292-4. PubMed ID: 4012738
    [No Abstract]   [Full Text] [Related]  

  • 20. Influenza vaccination and mortality in the United States.
    Kelly H; Vu T; Smith D
    Arch Intern Med; 2005 Sep; 165(17):2037-8; author reply 2039-40. PubMed ID: 16186476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.